Home > Healthcare > Pharmaceuticals > Vaccines > Pediatric Vaccines Market

Pediatric Vaccines Market Share

Report ID: GMI10161
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Pediatric Vaccines Market Share

The market is characterized by intense competition among key players aiming to expand their market presence. Leading companies are focusing on strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their market position. These efforts are aimed at enhancing their product offerings, expanding their geographic reach, and investing in advanced technologies.

Pediatric Vaccines Market Companies

The company profile section includes both companies that have commercial drug available in the market as well as those that are onto clinical phase development. Prominent players operating in the market are as mentioned below:

Astellas Pharma, Inc.
AstraZeneca Plc
CSL Limited
Daiichi Sankyo Company Limited
Emergent BioSolutions, Inc,
GlaxoSmithKline Plc
Grifol SA
Meissa Vaccines, Inc.
Merck & Co. Inc.
Panacea Biotec
Pfizer, Inc.
Sanofi SA
Serum Institute of India
Takeda Pharmaceutical Industries Limited

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global pediatric vaccines market was valued at USD 48.1 billion in 2023 and will grow at 8.9% CAGR over 2024-2032, driven by the rising prevalence of infectious and chronic diseases among children.

The multivalent pediatric vaccines industry held a revenue of USD 30 billion in 2023 and will expand rapidly through 2032, as they protect against multiple diseases with a single injection, making them highly desirable for comprehensive disease prevention.

North America pediatric vaccines market secured a 48.2% revenue share in 2023 and will expand through 2032, owing to strong presence of major pharmaceutical and biotechnology companies, driving innovation and development of new vaccines.

Astellas Pharma, Inc, AstraZeneca Plc, CSL Limited, Daiichi Sankyo Company Limited, Emergent BioSolutions, Inc, GlaxoSmithKline Plc, Grifol SA, Meissa Vaccines, Inc, Merck & Co. Inc, and Panacea Biotec among others.